Enlivex Therapeutics Ltd. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Enlivex Therapeutics Ltd. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2019 to Q2 2025.
  • Enlivex Therapeutics Ltd. Operating Lease, Liability, Noncurrent for the quarter ending June 30, 2025 was $216K, a 56.7% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $216K -$283K -56.7% Jun 30, 2025 6-K 2025-08-29
Q4 2024 $299K -$387K -56.4% Dec 31, 2024 6-K 2025-08-29
Q2 2024 $499K -$3.2M -86.5% Jun 30, 2024 6-K 2024-08-30
Q4 2023 $686K -$3.51M -83.6% Dec 31, 2023 20-F 2025-04-30
Q2 2023 $3.7M -$940K -20.3% Jun 30, 2023 6-K 2023-09-01
Q4 2022 $4.19M -$1.2M -22.2% Dec 31, 2022 20-F 2024-04-30
Q2 2022 $4.64M +$4.24M +1046% Jun 30, 2022 6-K 2022-08-22
Q4 2021 $5.39M +$4.89M +980% Dec 31, 2021 6-K 2022-08-22
Q2 2021 $405K +$169K +71.6% Jun 30, 2021 6-K 2021-08-06
Q4 2020 $499K +$201K +67.5% Dec 31, 2020 6-K 2021-08-06
Q2 2020 $236K Jun 30, 2020 6-K/A 2020-10-13
Q4 2019 $298K Dec 31, 2019 6-K/A 2020-10-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.